TrialRandomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Trial details
- Registry ID
- NCT03519386
- Phase
- Phase 3
Drug research
Sham surgery + active-comparator eye drops
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as Control Group
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%NCT03519386 | Glaukos Corporation | Phase 3 | Completed | 2022-04-05Actual |
| Clinical Study Comparing Two Models of a Travoprost Intraocular ImplantNCT03868124 | Glaukos Corporation | Phase 3 | Completed | 2022-06-10Actual |
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
Trial details
- Registry ID
- NCT03868124
- Phase
- Phase 3
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |